June 3, 2026 1:06 pm

Category: Life Stories

New Hope on the Horizon: TREMFYA® Gets NICE Approval for IBD

NICE has officially recommended TREMFYA® as a treatment for both Crohn’s disease and ulcerative colitis, offering new hope for patients who haven’t found success with previous therapies. This breakthrough represents a meaningful step forward for the IBD community, with evidence showing effectiveness across different patient populations.

Your Mouth Could Hold the Key to Better IBD Management

New research reveals a fascinating connection between oral bacteria and gut health that could change how we think about IBD management. Scientists have discovered that bacteria from our mouths can travel to our intestines and potentially influence inflammation, opening up new possibilities for treatment approaches that start with something as simple as better oral hygiene.

You Missed

Week of May 11-17, 2026: Seven IBD research stories worth your attention

Week of May 11-17, 2026: Seven IBD research stories worth your attention

May 17, 2026
Coffee, Alcohol, and Carbonated Drinks in IBD Remission: My Experience

Coffee, Alcohol, and Carbonated Drinks in IBD Remission: My Experience

May 13, 2026
Week of May 4-10, 2026: 10 IBD research stories worth your attention

Week of May 4-10, 2026: 10 IBD research stories worth your attention

May 10, 2026
How I Self-Assess Whether a New Crohn's Drug Is Actually Working

How I Self-Assess Whether a New Crohn’s Drug Is Actually Working

May 7, 2026